Determinants of Appropriate Use of Angiotensin-Converting Enzyme Inhibitors After Acute Myocardial Infarction in Persons ≥65 Years of Age

This publication has 13 references indexed in Scilit:

• Aspirin in the Treatment of Acute Myocardial Infarction in Elderly Medicare Beneficiaries
  Circulation, 1995
• Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarction
  The American Journal of Cardiology, 1995
• Quality of Care for Medicare Patients With Acute Myocardial Infarction
  JAMA, 1995
• Knowledge and Practices of Generalist and Specialist Physicians Regarding Drug Therapy for Acute Myocardial Infarction
  New England Journal of Medicine, 1994
• The Uniform Clinical Data Set: An Evaluation of the Proposed National Database for Medicare's Quality Review Program
  Annals of Internal Medicine, 1993
• Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1992
• The Health Care Quality Improvement Initiative
  Published by American Medical Association (AMA) ,1992
• Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
  Circulation, 1990
• Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
  New England Journal of Medicine, 1988
• Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.
  Circulation, 1985